PreAsthmaControl (PAC)

• Status: Completed
• Trial end date: 2004-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the ability of budesonide, given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing asthma

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• Children of asthmatic mothers form the COPSAC birth cohort study

Exclusion Criteria:

• Children born more than 4 weeks preterm

• children with other systemic illness that atopy/allergy

• Children requiring mechanical ventilation at any time since birth.